BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $92,300,000 | +89.7% | 610,571 | +82.9% | 0.28% | +79.1% |
| Q2 2022 | $48,644,000 | +916.6% | 333,839 | +869.2% | 0.16% | +690.0% |
| Q3 2021 | $4,785,000 | +309.7% | 34,446 | +152.8% | 0.02% | +233.3% |
| Q4 2020 | $1,168,000 | -77.1% | 13,627 | -88.9% | 0.01% | -82.9% |
| Q3 2019 | $5,099,000 | +19.6% | 122,231 | +25.6% | 0.04% | +29.6% |
| Q2 2019 | $4,263,000 | -56.5% | 97,341 | -63.2% | 0.03% | -62.0% |
| Q4 2018 | $9,795,000 | +3527.8% | 264,861 | +3577.6% | 0.07% | +7000.0% |
| Q3 2018 | $270,000 | -51.9% | 7,202 | -49.3% | 0.00% | -66.7% |
| Q2 2018 | $561,000 | – | 14,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |